US › Healthcare

Pro-Dex Inc (PDEX)

US · Healthcare · Medical Instruments & Supplies

$58.26-2.93%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$20.4M

Revenue YoY

+16.6%

Net profit

$2.9M

Profit YoY

+138.9%

EPS

$0.87

EPS estimate

$0.67

Net margin

14.0%

EPS came in at 0.87 against a street estimate of 0.67 — a beat of 29.9%.

Key statistics

Market cap

$201.3M

P/E

15.1

Forward P/E

23.4

P/B

4.87

Book value

$14.95

EPS (TTM)

$4.12

52-week high

$77.00

52-week low

$23.47

50-day MA

$66.44

200-day MA

$55.13

Beta

0.04

Analyst view

Analysts rate Pro-Dex Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $74.00.

Shareholding

Insiders

35.93%

Institutions

31.31%

Largest institutional holders

Fund	Stake
BlackRock Inc	4.74%
Vanguard Capital Management, LLC	2.54%
Dimensional Fund Advisors, Inc.	1.76%
Punch & Associates Inv Mgmt Inc	1.63%
Geode Capital Management, LLC	1.54%
JPMorgan Chase & Co	1.00%
State Street Corp	0.97%
The Goldman Sachs Group Inc	0.58%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pro-Dex Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.